Overview
Lobbying Costs
650,000€
Financial year: Jan 2014 - Dec 2014
Lobbyists (Full time equivalent)
3 Fte (7)
Lobbyists with EP accreditation
4
High-level Commission meetings
34
Lobbying Costs over the years
-
Info
SANOFI
EU Transparency Register
61291462764-77 First registered on 11 Dec 2009
Goals / Remit
Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs.
Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme (Rare Diseases)Main EU files targeted
- European Active & Health Ageing Partnership.
- EU/Canada Trade Agreement.
- The EU-US Transatlantic Trade and Investment Partnership (TTIP).
- Proposal for a Regulation of the European Parliament and of the Council on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC.
- Proposal for a Regulation of the European Parliament and Council establishing Horizon 2020 - the Framework Programme for Research and Innovation (2014-2020).
- Proposal for a Regulation of the European Parliament and Council laying down the rules for the participation and dissemination in Horizon 2020.
- Proposal for a Council regulation on the Innovative Medicines Initiative 2.
- Proposal for a regulation on the protection of individuals with regard to the processing of personal data and on the free movement of such data.
- Proposal for a regulation of the European Parliament and of the Council establishing a Health for Growth Programme, the third multi-annual programme of the EU action in the field of health for the period 2014-2020.
- Proposal for a directive of the European Parliament and of the Council on the activities and supervision of institutions for occupational retirement provision (recast).
- Proposal for a directive of the European Parliament and of the Council on Payment services in the internal market.
- Proposal for a regulation of the European Parliament and of the Council amending Council Regulation (EC) No 207/2009 on the Community Trade Mark.
- Proposal for a regulation on fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinales products for human use.
- Delegated act on the detailed rules for a unique identifier for medicinal products for human use and its verification.
- Public consultation on mobile health.Address
Head Office
SANOFI GROUPE
rue la Boétie, 54
Paris 75008
FRANCEEU Office
SANOFI - Brussels Office
14, rue de la Science
Bruxelles 1040
BELGIUM -
People
Total lobbyists declared
7
Employment time Lobbyists 75% 1 50% 3 25% 3 Lobbyists (Full time equivalent)
3
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
4 accreditations were / are live (in bold) for the selected state of 24 Apr 2015
Name Start date End Date Florence BARON PAPILLON 09 Feb 2024 07 Feb 2025 Jordan RANKIN 09 Mar 2024 07 Mar 2025 Mark CANAVAN 05 Mar 2024 04 Mar 2025 Milena RICHTER 09 Nov 2023 08 Nov 2024 Marie Helene FANDEL 18 Nov 2022 25 Oct 2023 Milena RICHTER 13 Oct 2022 13 Oct 2023 Milena RICHTER 18 Oct 2019 17 Oct 2020 Ms Clara ZACHMANN 01 Oct 2019 01 Oct 2020 Mr Jérémy Alain MICHEL 05 Oct 2018 05 Oct 2019 Milena RICHTER 05 Oct 2018 05 Oct 2019 Ms Clara ZACHMANN 19 Sep 2018 19 Sep 2019 Ms Katharina Lotz 17 Apr 2018 17 Apr 2019 Mr Jérémy Alain MICHEL 30 Oct 2017 05 Oct 2018 Milena RICHTER 30 Oct 2017 05 Oct 2018 Ms Clara ZACHMANN 16 Sep 2017 15 Sep 2018 Mr Darren KINSELLA 24 Mar 2017 03 Jan 2018 Milena RICHTER 19 Nov 2016 30 Oct 2017 Mr Jérémy Alain MICHEL 17 Nov 2016 30 Oct 2017 Mr Darren KINSELLA 23 Mar 2016 22 Mar 2017 Ms Corinne ASSOULINE-DUGUAY 05 Mar 2016 04 Mar 2017 Mr Jérémy Alain MICHEL 18 Nov 2015 16 Nov 2016 Milena RICHTER 18 Nov 2015 16 Nov 2016 Mr Hannu JOUHKI 10 Mar 2015 27 Feb 2016 Ms Corinne ASSOULINE-DUGUAY 27 Feb 2015 25 Feb 2016 Ms Corinne ASSOULINE-DUGUAY 21 Feb 2014 03 Mar 2015 Milena RICHTER 19 Nov 2014 17 Nov 2015 Mr Jérémy Alain MICHEL 19 Nov 2014 17 Nov 2015 Milena RICHTER 19 Nov 2014 27 Jan 2015 Mr Hannu JOUHKI 04 Mar 2014 03 Mar 2015 Mrs Corinne ASSOULINE-DUGUAY 21 Feb 2014 27 Jan 2015 Mr Jérémy Alain MICHEL 09 Nov 2013 08 Nov 2014 Milena RICHTER 18 May 2013 17 May 2014 Mrs Corinne ASSOULINE épouse DUGUAY 28 Feb 2013 19 Feb 2014 Mr Erick Denis François Robert TYSSIER 22 Jan 2013 13 Oct 2013 Mrs Danuta Marianna RYDLEWSKA 23 Jan 2013 08 Aug 2013 Mr Jérémy Alain MICHEL 22 Jan 2013 09 Nov 2013 Mr Erick Denis François Robert TYSSIER 22 Feb 2012 08 Feb 2013 Mrs Danuta Marianna RYDLEWSKA 01 Feb 2012 08 Feb 2013 Mr Jérémy Alain MICHEL 01 Feb 2012 08 Feb 2013 Mr Grégory LAMORY 02 Feb 2012 08 Feb 2013 Complementary Information
4 persons are full-time engaged in the Brussels Office and spend respectively 75% for one and 50% for the 3 others on the specific activities covered by the Register. The 3 others spend around 25% of their time.
Person in charge of EU relations
Ms Corinne DUGUAY (Vice President, European Public Affairs)
Person with legal responsibility
Mr Peter GUENTER (Executive Vice-President, Global Commercial Operations)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Professional associations
AESGP (Association of the European Self-Medication Industry).
AFEP (French Association of Private Companies).
EFPIA (European Federation of Pharmaceutical Industries Associations).
Think tanks
British chamber of commerce in Belgium
Confrontations Europe
EPC
Friends of EuropeMember organisations
Genzyme, Merial, Sanofi-Pasteur and Zentiva are member companies of the SANOFI GROUP which develop specific activities.
-
Financial Data
Closed financial year
Jan 2014 - Dec 2014
Lobbying costs for closed financial year
650,000€
Other financial info
/
-
EU Structures
Groups (European Commission)
Multi-Stakeholder Workshop Digigrow
ACC
None
Groups (European Parliament)
None
Communication activities
None foreseen.
Other activities
/
- Meetings
Meetings
34 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 19 Mar 2024 Location Brussels Subject industrial competitiveness of pharma sector Cabinet Cabinet of Commissioner Thierry Breton Attending - Thierry Breton (Commissioner)
-
Date 05 Mar 2024 Location Brussels Subject Discussion on IPCEI DG Competition Attending - Olivier Guersent (Director-General)
-
Date 17 Jan 2024 Location Davos Subject Meeting with Mr Roy Papatheodorou, SANOFI Executive Vice President and General Counsel Cabinet Cabinet of Commissioner Stella Kyriakides Attending - Stella Kyriakides (Commissioner)
- Giorgios Rossides (Cabinet member)
-
Date 14 Oct 2022 Location Brussels, Belgium Subject Pharmaceutical investments, implementation of the Pharma Strategy Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)
-
Date 07 Sep 2022 Location Webex Subject Meeting with the German Pharmaceutical Association and Sanofi to discuss the pharmaceutical reform Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
Other Lobbyists -
Date 10 Jun 2022 Location Videoconference Subject Discussion on stragegic foresight Cabinet Cabinet of Vice-President Maroš Šefčovič Portfolio Energy Union Attending - Dimitri Lorenzani (Cabinet member)
-
Date 10 Jun 2022 Location Videoconference Subject Discussion on stragegic foresight Cabinet Cabinet of Vice-President Maroš Šefčovič Portfolio Interinstitutional Relations and Foresight Attending - Dimitri Lorenzani (Cabinet member)
-
Date 08 Jun 2022 Location call Subject health industrial ecosystem, HERA and green transition Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 03 Feb 2022 Location Videoconference Subject Initiatives in the health industrial ecosystem Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 26 Oct 2021 Location Brussels Subject Pharmaceutical sector – trade related issues Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Elina Melngaile (Cabinet member)
- Kevin Keary (Cabinet member)
- Caroline Boeshertz (Cabinet member)
Other Lobbyists -
Date 16 Jun 2021 Location online Subject Supply chains for medicines Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
- Maria Luisa Llano Cardenal (Cabinet member)
Other Lobbyists - Bureau Européen des Unions de Consommateurs
- European Healthcare Distribution Association
- The European Association of Hospital Pharmacists
- Leuphana Universität Lüneburg
- MEDICINES FOR EUROPE
- Fresenius Kabi Deutschland GmbH
- Phamaceutical Group of the European Union
- European Federation of Pharmaceutical Industries and Associations
- Novo Nordisk A/S
- Teva Pharmaceuticals Europe BV
- Pfizer Inc.
- European Chemical Industry Council
- European Patients' Forum (EPF)
- Medichem, S.A.
-
Date 26 Mar 2021 Location Videoconference Subject Health in the industry policy update Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)
-
Date 31 Jan 2021 Location Videoconference Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
Other Lobbyists -
Date 23 Nov 2020 Location Brussels (WEBEX) Subject Alliances Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 16 Nov 2020 Location Videoconference Subject Pharmaceutical manufacturing in the EU Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
- Eszter Batta (Cabinet member)
-
Date 13 Oct 2020 Location Videoconference Subject Pharmaceutical manufacturing in the EU Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)
- Thierry Breton (Commissioner)
-
Date 25 May 2020 Location Videoconference Subject Perspectives on the fight against COVID-19 Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
-
Date 06 Apr 2020 Location Videoconference Subject Digitisation of healthcare and innovative e-health solutions. Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 21 Feb 2018 Location Brussels Subject HTA; Supplementary Protection Certificates (SPC) Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
Other Lobbyists -
Date 25 Jan 2018 Location Brussels Subject European patent protection Cabinet Cabinet of Commissioner Pierre Moscovici Portfolio Economic and Financial Affairs, Taxation and Customs Attending - Lucie Mattera (Cabinet member)
Other Lobbyists -
Date 24 Jan 2018 Location Brussels Subject Digital Healthcare Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Digital Economy and Society Attending - Manuel Mateo-Goyet (Cabinet member)
-
Date 24 Jan 2018 Location BRUSSELS Subject HTA; E-Health Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 10 Oct 2017 Location Brussels Subject Life Science in the EU Cabinet Cabinet of First Vice-President Frans Timmermans Portfolio Better Regulation, Interinstitutional Relations, the Rule of Law and the Charter of Fundamental Rights Attending - Bernardus Smulders (Cabinet member)
-
Date 18 Apr 2016 Location Brussels, Belgium Subject Access to health care including pharmaceuticals in developing countries Cabinet Cabinet of Vice-President Neven Mimica Portfolio International Cooperation & Development Attending - Nils Behrndt (Cabinet member)
-
Date 18 Apr 2016 Location Berlaymont Subject EPSC, Interinstitutional relations Cabinet Cabinet of President Jean-Claude Juncker Portfolio President Attending - Clara Martinez Alberola (Cabinet member)
-
Date 17 Mar 2016 Location Brussels Subject AMR, HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 02 Jul 2015 Location Brussels Subject vaccinations Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Paula Duarte Gaspar (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
-
Date 03 Jun 2015 Location Brussels Subject New College and Better Regulation DG Communications Networks, Content and Technology Attending - Robert Madelin (Director-General)
Other Lobbyists - Acumen Public Affairs
- European Academy of Dermatology and Venereology
- Novartis International AG
- FoodDrinkEurope
- Oracle
- Dow Europe GmbH
- GIGAEurope aisbl
- Toy Industries of Europe
- Syngenta Crop Protection AG
- European Centre for Public Affairs
- American Chamber of Commerce to the European Union
- RELX
- CEMBUREAU - The European Cement Association
- CEMA - European Agricultural Machinery Industry Association
- Cargill
- Jaguar Land Rover Limited
- Association des Constructeurs Européens d'Automobiles
- MERIAL
- spiritsEUROPE
- European Chemical Industry Council
- RTL Group
- The Walt Disney Company Benelux BVBA
-
Date 03 Jun 2015 Location Brussels Subject New College and Better Regulation DG Communications Networks, Content and Technology Attending - Robert Madelin (Director-General)
Other Lobbyists - European Centre for Public Affairs
- Jaguar Land Rover Limited
- American Chamber of Commerce to the European Union
- Association des Constructeurs Européens d'Automobiles
- CEMBUREAU - The European Cement Association
- spiritsEUROPE
- MERIAL
- European Academy of Dermatology and Venereology
- European Chemical Industry Council
- Novartis International AG
- RTL Group
- FoodDrinkEurope
- The Walt Disney Company Benelux BVBA
- Oracle
- Acumen Public Affairs
- GIGAEurope aisbl
- RELX
- Toy Industries of Europe
- Dow Europe GmbH
- CEMA - European Agricultural Machinery Industry Association
- Syngenta Crop Protection AG
- Cargill
-
Date 07 May 2015 Location Brussels Subject Implementation Council Conclusions on Vaccination Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Giulia Del Brenna (Cabinet member)
-
Date 27 Mar 2015 Location Berlaymont Subject How to strengthen a European coherent approach with focus on ERA development, ways to reduce the fragmented approach in Europe for evaluation the value of new medicines for improved access for the patient, and means of creating a more dynamic environment for medicine development in Europe and driving an ambitious agenda allowing the European life sciences sector to remain competetive on a global scale. Cabinet Cabinet of President Jean-Claude Juncker Portfolio President Attending - Clara Martinez Alberola (Cabinet member)
-
Date 19 Mar 2015 Location Brussels Subject New Commission, Investment plan, TTIP Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Juho Romakkaniemi (Cabinet member)
-
Date 19 Feb 2015 Location Berlaymont Subject Exchange of views in the perspective to present of Health & Growth and to discuss ERA, medicine development and its access for the patient Cabinet Cabinet of President Jean-Claude Juncker Portfolio President Attending - Clara Martinez Alberola (Cabinet member)
-
Date 21 Jan 2015 Location Brussels Belgium Subject A reflection on how Europe can move towards the development of a genuine European Research Area, benefiting from closer cooperation between the private and the academic and public sectors and better exploit the links between fundamental and translational research. Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Rolf Carsten Bermig (Cabinet member)
- Meetings